Health CarePharmaceuticals & Biotechnology
  • Price (USD)9.14
  • Today's Change0.06 / 0.66%
  • Shares traded124.07k
  • 1 Year change100.88%
  • Beta2.2758
Data delayed at least 15 minutes, as of Nov 21 2019 23:30 GMT.
More ▼

Events & Activity

  • PFNX:ASQ price moved over +1.64% to 8.97
  • PFNX:ASQ price rises above 50-day moving average to 9.17 at 09:30 GMT
  • PFNX:ASQ price rises above 50-day moving average to 9.20 at 09:36 GMT

Key statistics

On Thursday, Pfenex Inc (PFNX:ASQ) closed at 9.14, -19.75% below its 52-week high of 11.39, set on Nov 08, 2019.
52-week range
3.13Jan 02 201911.39Nov 08 2019
Markit short selling activity
Previous close9.08
Average volume290.92k
Shares outstanding31.68m
Free float29.27m
P/E (TTM)--
Market cap287.62m USD
EPS (TTM)-0.48
Data delayed at least 15 minutes, as of Nov 21 2019 23:30 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.